NEW 1 , 2 -DIARYL PYRAZOLES USEFUL AS ANALGETIC AND ANTI-INFLAMMATORY AGENTS
    93.
    发明授权
    NEW 1 , 2 -DIARYL PYRAZOLES USEFUL AS ANALGETIC AND ANTI-INFLAMMATORY AGENTS 有权
    镇痛和抗炎剂的合适的新的1,2-二芳基吡唑

    公开(公告)号:EP1915347B1

    公开(公告)日:2009-01-28

    申请号:EP06765404.6

    申请日:2006-07-27

    IPC分类号: C07D231/12 A61K31/4155

    CPC分类号: C07D231/12

    摘要: The present invention relates to new compounds of formula (I), (I) wherein the meaning of R1 is hydrogen atom, C1-C5 acyl group, benzoyl group or R2- COOR3 group, Y is hydrogen atom or alkali ion, R2 is C1-C4 straight or branched alkylidene group and R3 is hydrogen atom, C1-C4 alkyl group or alkali ion, and/or stereoisomers and/or diastereomers and/or pharmaceutically acceptable salts and/or hydrates and/or solvates thereof, which are suitable for the treatment of pain of acute and chronic inflammation origin as well as postoperative pain and dysmenorrhea. The invention also relates to the process of the synthesis of compounds of formula (I) as well as the pharmaceutical composition containing the same and the use for treatment of pain, inflammation and disorders associated with inflammation.

    NOVEL PROCESS FOR PRODUCTION OF 5-{2-Ý4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL¨-ETHYL}-6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE (ZIPRASIDONE)
    94.
    发明公开
    NOVEL PROCESS FOR PRODUCTION OF 5-{2-Ý4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL¨-ETHYL}-6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE (ZIPRASIDONE) 审中-公开
    工艺的5-(2-溴乙基)-6-氯-1,3-二氢-2H-吲哚-2-酮的制备

    公开(公告)号:EP2013203A2

    公开(公告)日:2009-01-14

    申请号:EP07733855.6

    申请日:2007-05-02

    IPC分类号: C07D417/12

    CPC分类号: C07D417/12

    摘要: The present invention provides a novel, industrially easily realisable and economically preferable process for production of pure 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one i.e., ziprasidone hydrochloride shown in the reaction scheme (II), (III), (IV), (V) and (VI). According to the invention the intermediate compound 5-(2-bromoethyl)-6-chloro-1,3-dihydro-2H-indol-2-one of Formula (III) is produced from 5-(2-bromoacethyl)-6-chloro-1,3-dihydro-2H-indole-2-one of Formula (IV). The highly pure ziprasidone base of Formula (II) is obtained in the reaction of 3-piperazinyl-1,2-benzisothiazol of Formula (VI) with 5-(2-bromoethyl)-6-chloro-1,3-dihydro-2H-indol-2-one of Formula (III) in an organic solvent or organic solvent mixture.

    PROCESS FOR THE SYNTHESIS OF N- [3-(3-CYANOPYRAZOLO [1,5A] PYRIMIDIN-7-YL)-PHENYL] -N-ETHYL-ACETAMIDE
    95.
    发明授权
    PROCESS FOR THE SYNTHESIS OF N- [3-(3-CYANOPYRAZOLO [1,5A] PYRIMIDIN-7-YL)-PHENYL] -N-ETHYL-ACETAMIDE 有权
    METHOD FOR合成N- [3-(3-氰基吡唑并[1,5-a]嘧啶-7-基)苯基] -N-乙基乙酰胺

    公开(公告)号:EP1711501B1

    公开(公告)日:2009-01-14

    申请号:EP05708499.8

    申请日:2005-01-31

    IPC分类号: C07D487/04

    CPC分类号: C07D487/04 C07C233/43

    摘要: The invention relates to N- [3- (3-cyanopyrazolo [1,5-a] pyrimidin-7-yl) - phenyl]-N-ethyl-acetamide of formula (IV) containing less than 0.2 % impurities, which is suitable for therapeutic application. Furthermore the invention relates to a process for the synthesis of therapeutically applicable compound of formula (IV) containing less than 0.2 % impurities by reacting the new intermediate N-{3-[3-(dimethylamino)-1-oxo-2-propenyl]phenyl}-N-ethyl­acetamide hydrochloride of formula (II) and 3-amino-4-pyrazol-carbonitrile base of formula (III) in an acid free medium. The invention also relates to the new N- {3- [3- (dimethylamino) -1- oxo -2- ­propenyl]phenyl } -N-ethyl-acetamide hydrochloride of formula (II). The invention also relates to a process for the synthesis of the new N- [3- [3, (dimethylamino)-1-oxo-2-propenyl]phenyl}-N-ethyl-acetamide hydrochloride of formula (II) having a purity of more than 99.5 %. Furthermore the invention relates to N-{3-[3-cyanopyrazolo (1,5-a) pyrimidin]­6 -yl-3- [ (3-N-ethyl-acetamido-phenyl) -3-oxo-propen-1-yl] - (pyrimidin-7-yl) -phenyl} - N-ethyl-acet-amide of formula (V), which is an isolated new impurity formed in 0.07 % yield during the synthesis of compound of formula (IV).